0000899243-20-000883.txt : 20200109
0000899243-20-000883.hdr.sgml : 20200109
20200109163240
ACCESSION NUMBER: 0000899243-20-000883
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200107
FILED AS OF DATE: 20200109
DATE AS OF CHANGE: 20200109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Haag-Molkenteller Cornelia
CENTRAL INDEX KEY: 0001748297
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38667
FILM NUMBER: 20518514
MAIL ADDRESS:
STREET 1: C/O UROVANT SCIENCES, INC.
STREET 2: 5151 CALIFORNIA AVENUE, SUITE 250
CITY: IRVINE
STATE: CA
ZIP: 92617
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Urovant Sciences Ltd.
CENTRAL INDEX KEY: 0001740547
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
BUSINESS PHONE: 949-226-6029
MAIL ADDRESS:
STREET 1: 5281 CALIFORNIA AVENUE
STREET 2: SUITE 100
CITY: IRVINE
STATE: CA
ZIP: 92617
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-01-07
0
0001740547
Urovant Sciences Ltd.
UROV
0001748297
Haag-Molkenteller Cornelia
C/O UROVANT SCIENCES, INC.
5281 CALIFORNIA AVENUE, SUITE 100
IRVINE
CA
92617
0
1
0
0
CMO/Urovant Sciences, Inc.
Common Shares
2020-01-07
4
A
0
62128
0.00
A
62128
D
25% of the Restricted Stock Units shall vest on January 7, 2021; the remaining Restricted Stock Units vest in 12 equal quarterly installments thereafter, subject to the Reporting Person providing continuous service to the Issuer through each such vesting date.
/s/ Bryan Smith, Attorney-in-Fact
2020-01-09